{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:44:26Z","timestamp":1770482666863,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.11.053","type":"journal-article","created":{"date-parts":[[2010,12,5]],"date-time":"2010-12-05T09:15:00Z","timestamp":1291540500000},"page":"1324-1331","source":"Crossref","is-referenced-by-count":12,"title":["Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria\u2013tetanus\u2013acellular pertussis\u2013inactivated poliovirus\u2013Haemophilus influenzae b conjugate\u2013hepatitis B vaccine at 2, 4, 6 and 12\u201314 months of age"],"prefix":"10.1016","volume":"29","author":[{"given":"Francisco","family":"Diaz-Mitoma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Tapiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Hoffenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela S.","family":"Zappacosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Radley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Boslego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Hesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash K.","family":"Bhuyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey L.","family":"Silber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (6)","key":"10.1016\/j.vaccine.2010.11.053_bib0005","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2006.09.037","article-title":"Smallpox vaccines: past, present, and future","volume":"118","author":"Parrino","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"April (19)","key":"10.1016\/j.vaccine.2010.11.053_bib0010","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.vaccine.2008.11.115","article-title":"Safety and immunogenicity of a hexavalent diphtheria\u2013tetanus\u2013acellular pertussis\u2013inactivated poliovirus\u2013Haemophilus influenzae b conjugate\u2013hepatitis B vaccine at 2, 3, 4, and 12\u201314 months of age","volume":"27","author":"Halperin","year":"2009","journal-title":"Vaccine"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2010.11.053_bib0015","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2500\/aap.2006.27.2896","article-title":"Immunization update and hot topics in clinical immunology: how does this relate to my practice?","volume":"27","author":"Bellanti","year":"2006","journal-title":"Allergy Asthma Proc"},{"issue":"October (45)","key":"10.1016\/j.vaccine.2010.11.053_bib0020","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.vaccine.2008.07.101","article-title":"Epidemiology of poliomyelitis\u2014options and update","volume":"26","author":"Dutta","year":"2008","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.053_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.imlet.2008.11.009","article-title":"Principles of vaccination and possible development strategies for rational design","volume":"122","author":"Boog","year":"2009","journal-title":"Immunol Lett"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2010.11.053_bib0030","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1472-698X-9-S1-S2","article-title":"Global immunization: status, progress, challenges and future","volume":"9","author":"Duclos","year":"2009","journal-title":"BMC Int Health Hum Rights"},{"issue":"November (48)","key":"10.1016\/j.vaccine.2010.11.053_bib0035","first-page":"418","article-title":"Progress in global measles control and mortality reduction, 2000\u20132006","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.11.053_bib0040","first-page":"173","article-title":"Measles control and the prospect of eradication","volume":"330","author":"Moss","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.11.053_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(08)70152-X","article-title":"Haemophilus influenzae type b conjugate vaccine use and effectiveness","volume":"8","author":"Morris","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.11.053_bib0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.110.4.653","article-title":"Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis","volume":"110","author":"Zhou","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.11.053_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2010.11.053_bib0060","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-540-69297-3_10","article-title":"Cancer prevention by vaccination against hepatitis B","volume":"181","author":"Chang","year":"2009","journal-title":"Recent Results Cancer Res"},{"issue":"April (12)","key":"10.1016\/j.vaccine.2010.11.053_bib0065","first-page":"241","article-title":"Ten great public health achievements\u2014United States, 1900\u20131999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"April (16)","key":"10.1016\/j.vaccine.2010.11.053_bib0070","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2008.02.008","article-title":"Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.11.053_bib0075","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/INF.0b013e318187d047","article-title":"Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population","volume":"28","author":"Happe","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2010.11.053_bib0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pedhc.2007.09.004","article-title":"Societal impact of combination vaccines: experiences of physicians, nurses, and parents","volume":"22","author":"Koslap-Petraco","year":"2008","journal-title":"J Pediatr Health Care"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.11.053_bib0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2010.11.053_bib0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mph.2003.42","article-title":"Communicating the benefits of combination vaccines to parents and health care providers","volume":"17","author":"Koslap-Petraco","year":"2003","journal-title":"J Pediatr Health Care"},{"issue":"October (39)","key":"10.1016\/j.vaccine.2010.11.053_bib0095","first-page":"1079","article-title":"Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2010.11.053_bib0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/0148581-200810060-00008","article-title":"DTaP-IPV\/Hib vaccine (Pentacel)","volume":"10","author":"Dhillon","year":"2008","journal-title":"Paediatr Drugs"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2010.11.053_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.3.2.119","article-title":"Recombivax-HB: perspectives past, present and future","volume":"3","author":"Venters","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.11.053_bib0110","series-title":"Canadian immunization guide","author":"Immunization","year":"2006"},{"issue":"51 & 52","key":"10.1016\/j.vaccine.2010.11.053_bib0115","first-page":"Q1","article-title":"Recommended Immunization Schedules for Persons Aged 0 Through 18 Years\u2014United States","volume":"57","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"September (9 Suppl.)","key":"10.1016\/j.vaccine.2010.11.053_bib0120","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1097\/00006454-199809001-00004","article-title":"Haemophilus influenzae type b vaccines: history, choice and comparisons","volume":"17","author":"Decker","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2010.11.053_bib0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1191\/0962280204sm363ra","article-title":"Use of the false discovery rate for evaluating clinical safety data","volume":"13","author":"Mehrotra","year":"2004","journal-title":"Stat Methods Med Res"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.11.053_bib0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Stat Med"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2010.11.053_bib0135","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/hv.1.6.2377","article-title":"Safety and immunogenicity of two formulations of a hexavalent diphtheria\u2013tetanus\u2013acellular pertussis\u2013inactivated poliovirus\u2013Haemophilus influenzae conjugate\u2013hepatitis B vaccine in 15 to 18-month-old children","volume":"1","author":"Halperin","year":"2005","journal-title":"Hum Vaccin"},{"issue":"February (15\u201316)","key":"10.1016\/j.vaccine.2010.11.053_bib0140","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0264-410X(00)00403-5","article-title":"A combined liquid Hib (PRP\u2013OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity","volume":"19","author":"Nolan","year":"2001","journal-title":"Vaccine"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.11.053_bib0145","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.149.12.3978","article-title":"Effect of Haemophilus influenzae polysaccharide outer membrane protein complex conjugate vaccine on macrophages","volume":"149","author":"Ambrosino","year":"1992","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10016877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T11:12:34Z","timestamp":1685877154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10016877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10016877"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}